Skip to main content
. 2021 Dec 16;12:778204. doi: 10.3389/fimmu.2021.778204

Figure 4.

Figure 4

IFNAR2 splice variants under IFN-β treatment. (A) Correlation analysis between the transmembrane (IFNAR2) and soluble (sIFNAR2) transcripts before (r=0.636 p< 0.001) and after 6 months of IFN-β therapy onset (r=0.749 p<0.001). (B) Comparison of the relative expression of IFNAR2 versus sIFNAR2 before and after 6 months of IFN-β therapy onset, using GAPDH as a raeference gene (N=41). Significant p-values are shown with asterisk.